维普期刊资源整合服务平台（V6.5）

30篇 您的检索式：作者名="Woelber"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Assessment of cervical intraepithelial neoplasia (CIN) with colposcopic biopsy and efficacy of loop electrosurgical excision procedure (LEEP)显示文摘	Nina Duesing Joerg Schwarz Matthias Choschzick Fritz Jaenicke Friederike Gieseking Rana Issa Sven Mahner Linn Woelber	2012	Archives of Gynecology and Obstetrics2012，，6：	2
2	Clinicopathological prognostic factors and patterns of recurrence in vulvar cancer显示文摘	WOELBER L MAHNER S VOELKER K	2009	Anticancer Res2009，29，2：	1
3	Clinicopathological prognostic factors and patterns of recurrence in vulvar cancer 显示文摘	Woelber L Mahner S Voelker K	2009	Anticancer Res2009，29，2：	1
4	Clinicopathological prognostic factors and patterns of recurrence in vulvar cancer显示文摘	Woelber L Mahner S Voelker K	2009	Anticancer Res2009，29，：	1
5	Prognostic significance of CA- 125 in the management of patients with recurrent epithelial ovarian carcinoma selected for secondary cytoreduction 显示文摘	Mahner S Woelber L Jung S ct al	2009	Anticancer Res2009，29，7：	1
6	Carbonic anhydrase IX in tumor tissue and sera of patients with primary cervical cancer显示文摘	Woelber L Kress K Kersten JF	2011	BMC Cancer2011，11，11：	1
7	Decemen- tation Rates and the Peri-Implant Tissue Status of Im- plant-Supported Fixed Restorations Retained via Zinc Oxide Cement : A Retrospective 10-23 -Year Study 显示文摘	Woelber JP Ratka-Krueger P Vach K	2015	Clin Implant Dent Relat Res2015，28，1：	1
8	Serum carbonic anhydrase IX during first-line therapy of ovarian cancer 显示文摘	Woelber L Mueller V Eulenburg C	2010	Gynecol Oncol2010，117，2：	1
9	Perioperative morbidity and outcome of secondary cytoreduction for recurrent epithelial ovarian cancer显示文摘	Woelber L Jung S Eulenburg C		0，，06：	1
10	Association between tourniquet use and intraoperative blood loss during below-knee amputation显示文摘BACKGROUND Despite over 150000 amputations of lower limbs annually,there remains a wide variation in tourniquet practice patterns and no consensus on their necessity,especially among orthopedic patient populations.The purpose of this study was to determine whether tourniquet use in orthopedic patients undergoing below knee amputation(BKA) was associated with a difference in calculated blood loss relative to no tourniquet use.AIM To determine if tourniquet use in orthopedic patients undergoing BKA was associated with a difference in calculated blood loss relative to no tourniquet use.METHODS We performed a retrospective review of consecutive patients undergoing BKA by orthopedic surgeons at a tertiary care hospital from 2008 through 2018.Blood loss was calculated using a combination of the Nadler equation for preoperative blood volume and a novel formula utilizing preoperative and postoperative hemoglobin levels and transfusions.Univariate and forwards step-wise multivariate linear regressions were performed to determine the association between tourniquet use and blood loss.A Wilcoxon was used to determine the univariate relationship between tourniquet use and blood loss for in the restricted subgroups of patients who underwent BKA for trauma,tumor,and infection.RESULTS Of 97 eligible patients identified,67 underwent surgery with a tourniquet and 30 did not.In multivariate regression,tourniquet use was associated with a 488 mL decrease in calculated blood loss(CI 119-857,P = 0.01).In subgroup analysis,no individual group showed a statistically significant decrease in blood loss with tourniquet use.There was no significant association between tourniquet use and either postoperative transfusions or reoperation at one year.CONCLUSION We found that tourniquet use during BKA is associated with decreased calculated intraoperative blood loss.We recommend that surgeons performing this procedure use a tourniquet to minimize blood loss.	Alden E Wyland Erik Woelber Liam H Wong Jordan Arakawa Zachary M Working James Meeker	2022	World Journal of Orthopedics2022，13，7：	1
11	Perioperative morbidity and outcome of secondary cytoreduction for recurrent epithelial ovarian cancer显示文摘	Woelber L Jung S Eulenburg C	2010	Eur J Surg Oncol2010，36，6：	1
12	Prognostic significance of CA-125 in the management of patients with recurrent epithelial ovarian carcinoma selected for secondary cytoreduction 显示文摘	Mamner S Woelber L Jung S	2009	Anti-ancer Res2009，29，7：	1
13	Carbonic anhydrase IX in tumor tissue and sera of patients with primary cervical cancer显示文摘	Woelber L Kress K Kersten J F	2011	BioMed Central Cancer2011，11，：	1
14	Prognostic signifi cance of CA-125 in the management of patients with re current epithelial ovarian carcinoma selected for seconda ry cytoreduetion显示文摘	Mahner S Woelber L Jung S	2009	Anticancer Res2009，29，7：	1
15	Clinicopathologi- cal prognostic factors and patterns of recurrence in vulvar cancer显示文摘	Woelber L Mahner S Voelker K	2009	Anticancer Res2009，29，2：	1
16	Prognostic significance of CA-125 in the management of patients with recurrent epithelial ovarian carcinoma selected for secondary cytoreduction显示文摘	MAHNER S WOELBER L JUNG S	2009	Anticancer Res2009，29，7：	1
17	Perioperative morbidity and outcome of secondary cytoreduetion for recurrent epithelial ovarian cancer显示文摘	Woelber L Jung S Eulenburg C	2010	Eur J Surg Oncol2010，36，6：	1
18	Clinical manage- ment of epithelial ovarian cancer during pregnancy显示文摘	Grimm D Woelber L Trillsch F	2014	Eur J Cancer2014，50，5：	1
19	Assessment of endodontic treatment of c-shaped root canals显示文摘	Woelber JP Bruder M Tennert C	2014	Swiss Dent J2014，12，1：	1
20	Perioperative morbidity andoutcome of secondary cytoreduction for recurrent epithelial ovariancancer显示文摘	Woelber L Jung S Eulenburg C	2010	Eur J Surg Oncol2010，36，6：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示